July 06, 2020
In early June, AstraZeneca approached rival drugmaker Gilead Sciences to discuss a potential merger. Though some doubt the feasibility of such a deal, this would be the biggest healthcare merger on record.
June 11, 2020
On this year’s World IP Day, WIPO Director General Francis Gurry called for a surge in green tech patenting to fight climate change. His charge follows a report that patenting for green energy technologies has slowed.
June 05, 2020
As legal tech revolutionizes the industry, offering new avenues for speed, accuracy, and quality assurance in legal work, often, one roadblock remains - the budget-minded CFO.
March 23, 2020
Biopharmaceutical companies AbbVie Inc. and Allergan recently announced that they signed a consent decree with the U.S. Federal Trade Commission that will commit the companies to sell some properties if they commence a planned merger.
Big business is all about data. We see it in almost every industry, from healthcare to financial services to aviation and beyond. But the legal industry has been slow to adapt.
January 06, 2020
2020 is officially here! In order to best prepare for the new year in patent policy, let's take a look at some top stories from 2019 with a lasting impact.
November 19, 2019
Fiat Chrysler and Peugeot owner PSA Group recently announced the terms of a $48 billion merger that would create the world's fourth-largest automaker. A primary reason for the merger is to share the cost of developing electric and autonomous vehicles.
October 21, 2019
The next big technology shakeup is on its way. With a limited rollout in 2018 leading to a much more comprehensive release in 2020, 5G is here, with increased speeds, instantaneous communication, and the ability to connect just about everything.
October 07, 2019
In an update to our 2016, 2017, and 2018 lists of most difficult examiners at the USPTO, we have identified the 10 patent examiners (excluding SPEs) with the most skeptical eye toward the patent applications that cross their desks.
August 15, 2019
Pfizer and Mylan, the maker of EpiPens, are merging. Pfizer will offload Upjohn, its portfolio of drugs that are no longer protected by patents, including Viagra, Lipitor and Celebrex, combining with rival Mylan to create a new company that will have a new, yet-to-be-announced name.